On the surface, it seemed like a good case. Sandoz Inc., Lupin Pharmaceuticals Inc. and several other generic drugmakers challenged a 2010 patent on Allergan's Lumigan eye drops for treating glaucoma.
DEAR DR. ROACH: I am a 74-year-old woman who was diagnosed with open angle glaucoma several years ago. My ophthalmologist has directed me to use Simbrinza three times a day in my right eye and Lumigan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results